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 Summary
 Background: Pancreatic cancer is one of the most malignant tumors. Symptoms are usually nonspecific and 
insidious such that the cancer is advanced by the time of diagnosis.
  The aim of our work was to investigate the use of MRI and MRCP in diagnosis of the patients 
suspected of pancreatic carcinoma and to determine the role of these methods in the evaluation of 
resectability of pancreatic cancer in comparison to surgical findings.
 Material/Methods: Forty-nine patients (33 men and 16 women) aged 44–82 had undergone to MRI and MRCP 
imagination of the upper abdomen on 1.5 T system with use of a standard flexible surface coil. 
The results of those radiological diagnostic tests were compare to the surgical findings and 
histopathological examination. The capacity of MR and MRCP to detect pathological mass, assess 
disease process nature and accuracy of assessment of the resectability of the malignant lesion were 
evaluated. In the statistical analysis test X2 and Fisher's precise test were performed.
 Results: A statistical analysis determined 88% sensitivity, 95% specifity and 94% exactness of MRI and 
MRCP in the evaluation of nature of tumors within the pancreas and 100% sensitivity, 91% 
specificity and 95% accuracy in determining the resectability of the lesion. The positive predictive 
value came to 83%, while the negative predictive value to 100%. The Kappa compatibility index in 
comparison with a surgical findings came to 0.85714.
 Conclusions: MR and MRCP appears an important stage in diagnosis and in assessment of pancreatic tumors. By 
the estimation of tumor respectability it aids clinical management.
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Background
Pancreatic carcinoma represents the second most common 
cause of death from malignant tumors of the gastrointesti-
nal tract [1]. It is marked by unfavorable prognosis due to 
difficulties in early diagnostics, its aggressive character and 
low efficiency of medical proceedings [2,3]. An early detec-
tion of the tumor as well as the correct staging of disease 
are the key factors in the pancreatic cancer diagnosis. In 
the case of clinically suspected pancreatic cancer the most 
frequently used diagnostic methods are: ultrasound (US), 
endoscopic retrograde cholangiopancreatography (ERCP), 
computer tomography (CT).
The dynamic development of nuclear magnetic reso-
nance techniques (MRI), especially the introduction of 
rapid breath-hold sequences, dynamic scanning after 
the administration of the contrast medium, as well as 
the introduction of the cholangiopancreatography of the 
magnetic resonance (MRCP), evoked a lot of interest in 
this new, non-invasive diagnostic method in the medical 
world.
In recent years a series of clinical researches have been 
implemented, which the final point was the comparison 
of the usefulness of MRI and MRCP to the commonly used 
diagnostic methods such as CT and ERCP [4–6].
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The objectives of the thesis were:
•  to asses the usefulness of the magnetic resonance (MRI) 
expanded by the cholangiopancreatography technique 
of the magnetic resonance (MRCP) in diagnosis of the 
patients who are suspected of having pancreatic carci-
noma on the basis of clinical, laboratory and radiological 
examinations (US, CT).
•  to define he defining of usefulness of MRI and MRCP in 
the evaluation of resectability of pancreatic cancer in 
comparison to surgical findings.
Material and Methods
The research has been carried out in the Radiology 
Department as well as in the Clinic of General Surgery and 
Endocrinological of the Medical University in Bialystok. 
The examination protocol was approved by local ethics 
committee at the Medical University in Bialystok.
From January 2001 to September 2003, 49 patients referred 
to our hospital with a suspected pancreatic tumor. Of the 49 
patients included in this study, 33 were men and 16 were 
women, ranging in the age between 44 and 82 years (mean age 
65 years ±18). All patients had undergone to MRI and MRCP 
imagination. The results were compare to histopathological 
examinations (n=36) or to the biopsy results (n=11) and to 
the surgical findings and. Based on the MRI or MRCP imagi-
nation the resectability of malignant tumor was assessed.
All MRI scans were obtained using a 1.5 T MRI scanner 
(Picker Edge Eclipse, Picker Interantional Inc., Highland 
Heights, USA) with use of a standard flexible surface coil. 
Imaging sequences with T1-weighted FAST scan (TR 105 ms, 
TE 4.47 ms, 6 mm thick sections) pre and post i.v. contrast 
media administration (0.2 mmol/kg, Megnevist, Schering) 
were performed. Express T2-weighted series (TR 15000 
ms, PTE 105, 6.5 mm thick sections) were used. MRCP was 
performed with heavily T2-weighted HASTE sequence (PTE 
240 ms, TR 8000, 7mm thick sections). For better distinc-
tion between bile and intra- and retroperitoneal fat we used 
FatSat sequence (TE 4.47 ms, TR 160 ms, 6.5 mm thick sec-
tions). Each patient has starved (including water) for 2 hours 
before examination. For better evaluation of the stomach 
and the duodenum some patients were given orally contrast 
medium Magnevist Enteral (Schering AG). The total study 
time averaged 20-30 min, breath hold 20 s per sequence.
The radiological assessment included: signal intensity 
alteration of pancreatic parenchyma; mass effect, tumor 
diameter; morphology of the pancreatic duct; morphology 
of the bile ducts; encasement of blood vessels; invasion of 
adjacent structures; assessment of lymph nodes; distant 
metastases.
MR imaging interpretation
The region within the pancreas was suspected of the pres-
ence of carcinoma when alterations of the proper anatomi-
cal contours of the organ were found. Especially with the 
presence of focus which signal intensity of the pancreat-
ic parenchyma in the T1-weighted images was relatively 
decreased and it demonstrated hypointense, isointense or 
slightly hyperintense signal in T2-weighted sequences. 
After the intravenous contrast media administration the 
area did not indicate enhancement. Early local invasion 
was suspected when in T1-weighted time changes in signal 
intensity of extra-peritoneal adipose tissue was observed.
As a more advanced local invasion The malignant infil-
tration of peri-pancreatic vessels was regarded. The ves-
sel infiltration was very unlikely if less than one-quarter 
the circumference of the vessel was contiguous with the 
tumor. The case had to be considered equivocal if 25–50% 
the circumference of the vessel was contiguous with the 
tumor. There was a high likelihood of the vessel infiltration 
in cases in which more than one-half the circumference of 
the vessel was contiguous with the tumor. The presence of 
hydroperitoneum, enlargement of lymph nodes (the diam-
eter above 1.0 cm) as well as distant metastases settled the 
question of unresectability of the tumor regardless of the 
local staging of the disease.
Surgical confirmation
The exactness of MRI and MRCP in the assessment of the 
staging of pancreatic cancer was compared to the surgical 
findings. The surgeon while performing an operation was 
informed about the results of radiological examination. Each 
parameter which influence the decision of tumor resectabil-
ity were evaluated (infiltration of blood vessels, enlarge-
ment of lymph nodes, liver and/or peritoneum metastases). 
The operating surgeon classified the findings as positive or 
negative. The palpable mass detection within the pancreas 
fixed to peri-pancreatic blood vessels was regarded as the 
evidence of unresectability of the tumor. The size and local-
ization of the changes was also evaluated. The liver and 
peritoneum inspection was carried out by means of palpable 
examination, visual assessment, as well as biopsy.
The final verification in relation to the operated patients 
(n=36) constituted histopathological examination of the 
collected intra-operatively material. It included the histo-
pathological diagnosis with the assessment of the staging 
in case of the malignant process (according to TNM classi-
fication /tumor-nodes-metastases/) as well as the operative 
margin assessment. In the case of non – operated patients 
(n=10) cytological examination of bioptical specimens was 
performed.
Data analysis
The capacity of MR and MRCP was evaluated to:
• detection of pathological mass within pancreas,
• estimation of tumor size,
• accuracy of assessment of the disease process nature,
•  accuracy of assessment of the respectability of the malig-
nant lesion.
The lesions visualized in MR and MRCP examination was 
defined as malignant, benign or questionable and then they 
were compared to results of histopathological examination.
In order to assess the clinical usefulness of MR and MRCP 
in statistical analysis the following values were determined:
•  sensitiveness – the ability to diagnose pathological cases 
in all patients,
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•  specificity – the general ability to confirm lack of disease 
in healthy patients,
•  exactness – the general ability of the method for the 
detection of pathological cases as well as lack of presence 
of the disease,
•  positive prediction index – determines the likelihood 
of disease confirmation in patients with positive test 
results,
•  negative prediction index – determines the probability of 
disease exclusion on the basis of verification examina-
tion,
•  Kappa index – determines compatibility of classification 
of the methods.
According to prediction of resectability of pancreatic car-
cinoma the patients were divided into four groups (Table 1): 
I –  true positive (TP) – patients subjected to operation, 
who did not indicate the infiltration of blood vessels or 
metastases, neither in MR and MRCP nor in the course 
of the operation,
II –  true negative (TN) – patients, who on MR and MRCP 
examinations indicated the presence of the blood ves-
sels infiltration or metastases within abdominal cavity, 
which was confirmed in laparotomy,
III –  false positive (FP) – on the basis of MR and MRCP 
examinations the disclosed changes were determined 
as resectable, which was not confirmed during opera-
tion,
IV –  false negative (FN) – patients who did not meet the 
criterion of resectability of the lesion in MR and MRCP 
examinations and who were next operated.
The unresectable cancer was judged as any tumor with 
accompanying metastases in liver, peritoneum, with the 
encasement of peripancreatic blood vessels, thrombosis 
of splenic vein, superior mesenteric or portal vein or local 
proliferation with affection of surrounding organs (other 
than duodenum) or enlargement of lymph nodes (above 1.0 
cm – other than peripancreatic).
Resectable cancer was defined as any tumor judged to have 
been totally removed at surgery, without macroscopic evi-
dence of residual tumor and without evidence of involve-
ment of neighboring organs (other than duodenum) or 
hematogenous or distant lymph node metastases (other 
than peripancreatic nodes).
The remote survival assessment was possible in case of 20 
patients affected with pancreatic carcinoma, who arrived 
at the follow-up examination.
The information about the patients were collected on indi-
vidual forms and put in a computer database in Windows 
XP Professional Operational System. The thesis was written 
in Microsoft Office Word processor.
In the statistical analysis comparing qualitative features 
between the chosen groups the independence test X2 and 
Fisher's precise test were performed, p<0.05 was taken as 
the gravity level.
The results obtained on the basis of the collected material 
analysis were presented in tabular and graph forms.
Results
The average age of 49 patients qualified for the examina-
tion was 65 (±18). The clinic material constituted in 68% of 
men (n=33) and in 32% of women (n=16).
Histopatologicaly the following results were obtained: ade-
nocarcinoma (n=37), serous cystadenoma (n=2), chronic 
pancreatitis with inflammatory tumor (n=6), lymphoma 
(n=1), cholangiocarcinoma (n=1).
The tumors were mainly localized within the head (n=36), 
body (n=9) and tail (n=2) of the pancreas.
Based on MR and MRCP examination, the presence of 
pathological mass within the pancreas was diagnosed in all 
patients. In 39 cases the nature of tumor was defined as 
malignant, in 6 cases as benign and in 2 as questionable. 
Out of the group of all patients with diagnosed malignant 
process, in 27 patients (69%) pancreatic tumor was quali-
fied as unresectable on the basis of MR and MRCP assess-
ment criteria, whereas in 12 cases (30%) the lesion within 
the pancreas were recognized as resectable.
In six cases the cause of unresectability of the lesion was 
the detection in MR examination metastases in the liver 
without visible features of infiltration of peripancreatic 
blood vessels. The local progression of the disease with 
the infiltration of blood vessels concerned 21 cases, and 
additionally metastatic focuses in liver were revealed in 
3 patients. In 15 cases the local vascular encasement was 
displayed. In 3 cases the infiltration of celiac trunk and 
superior mesenteric artery were revealed, in 2 patients 
cancerous process afflicted the portal and the mesenteric 
veins. In 1 case the contact of the tumor with the infe-
rior vena cave and the superior vena cave walls was dis-
closed.
In three cases the infiltration of the celiac trunk and supe-
rior mesenteric artery were revealed, in two patients the 
cancerous process afflicted the portal and mesenteric veins. 
Test results Pancreatic carcinoma
Absent of
pancreatic
carcinoma
Positive
Negative
TP
FN
FP
TN
True-positive ratio = 
TP
--------------
TP+FN
True-negative ratio =
TN
-----------------
TN+FP
Accuracy =
TP+TN
-------------------------
TP+FN+TN+FP
Table 1. Diagnostic value of the test.
TP – true positive; TN – true negative; FP – false positive; FN – false 
negative.
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In 1 case contact of the tumor with inferior vena cava wall 
was present.
In 16 patients in the MRI examination the presence of 
enlarged lymph nodes was determined.
In the majority of patients in the MRCP examination a good 
degree of visualization of bile ducts and pancreatic ducts 
was obtained. In 3 cases the images were not diagnostic 
enough due to the presence of liquid reservoirs within the 
epigastrium (n=1) or a lack of patient cooperation (n=2).
In the MRCP examination usually a sudden narrowing of 
the main pancreatic duct with the distal part extensions, 
and visible in some cases, extended secondary ducts were 
observed most frequently. In 14 cases (38%) the so called 
“double duct sign” – which is the extension of the common 
pancreatic duct and the intrahepatic bile ducts as well as 
the Wirsung's duct.
Out of 27 patients with the lesions qualified as unresect-
able according to MRI and MRCP assessment criteria, 
the laparotomy associated with the palliative operation 
was carried out in 24 patients. In those patients (n=24) a 
surgical verification confirmed the unresectability of the 
tumor. In 3 remaining patients a biopsy was performed. 
All patients with a MRI and MRCP confirmed unresect-
ability of lesion (n=27), revealed the presence of adenocar-
cinoma when examined histopathologically. The MRI and 
MRCP imagination allowed the correct determination of 
the malignant nature as well as the unresectability of the 
tumor in the examined group of patients (n=27). The lapa-
rotomy revealed the presence of small metastases in the 
peritoneum in one of the patients, which were not detected 
by MRI.
The twelve patients, with the malignant tumor within the 
pancreas diagnosed on MRI and MRCP imagination, still 
meeting the criteria of resectability were consequently sub-
jected to operation. A certain divergence occurred between 
the results of MRI and MRCP and the surgical findings in 
the 3 cases. In one of those cases the presence of metastases 
in the peritoneum and mesenteric lymph nodes was indi-
cated, and in another one the tumor mass connection to the 
portal vein, which was not visualized on the MRI examina-
tion. In the last case the cause of divergences of the MRI 
results and laparotomy was the presence of the metastases 
in the group of mesenteric and hepatic lymph nodes as well 
as the superior mesenteric vein infiltration.
In one of the patients with inflammatory symptoms in the 
pancreas, after the administration of a paramagnetic con-
trast medium a hypointense area, suspected of the carcino-
genic transformation, in T1-weighted sequence within the 
head of the pancreas was detected. Performed in this case 
histopathological analysis revealed the presence of lesion of 
the inflammatory nature.
In nine patients with the tumors based on MRI exami-
nation classified as respectable, without enlarged lymph 
nodes, whereas in 4 cases the presence of cancerous 
cells was stated in the samples of the neighboring lymph 
nodes.
In the group of twelve patients subjected to operation 
due to malignant nature of tumor but meeting the resect-
ability criteria, histopathological examination stated: in 9 
cases – adenocarcinoma, in 1 case – lymphopma, in 1 case 
– cholangiocarcinoma of the intrapancreatic part of duct, 
and in 1 case – chronic inflammation with an inflamma-
tory tumour.
In 2 patients the MRI and MRCP examinations revealed the 
presence of cystic lesion with a few septa within the pan-
creas head (lesion determined as questionable in the MRI 
examination). There was no possibility to exclude the pres-
ence of the malignant cystoid tumour (cystodenocarcino-
ma) on the base of MRI imagination. In such cases a histo-
pathological examination diagnosed the presence of benign 
lesions – the serous cystadenoma type.
Using the MRI and MRCP assessment criteria the presence 
of benign lesions (in the course of a chronic inflammation) 
was revealed in six patients.
In one case the MRI and MRCP imaging indicated the pres-
ence of a slightly narrowed pancreatic duct crossing the 
hypointense lesion as well as small cysts within the tumor 
mass which can correspond to the extended branches of the 
main duct. This tumor was classified (according to MRI and 
MRCP) as a benign one. The carried out biopsy revealed the 
presence of inflammatory tumor. The patient was then sub-
sequently subjected to a long-term observation.
In one case with a histopathologically confirmed adeno-
carcinoma (T2 according to the TNM classification) certain 
inflammatory alterations were revealed through the MRI 
and MRCP examinations. The lesions within the head of the 
pancreas revealed in 4 remaining patients in the MRI and 
MRCP methods in T1-weighted sequence demonstrated a 
slightly reduced signal in comparison with the correct pan-
creatic parenchyma, of a heterogeneous enhancement on 
the sequences after contrast medium administration. In the 
MRCP the irregular extension of the main pancreatic duct 
was noticed accompanied by extended secondary ducts as 
well as with isolated pseudocysts and small areas of short-
ening of the T2 relaxation time. The biopsy and the his-
topathological examination proved the presence of inflam-
matory lesion. Those patients were later provided with a 
periodical medical control.
A statistical analysis carried out determined 87% sensitiv-
ity, 97% specifity and 95% exactness of MRI and MRCP in 
the evaluation of nature of tumors within the pancreas 
(Figure 1).
The MRI and MRCP imagination were marked by a 100% 
sensitivity, 90% specificity and 93% accuracy in determin-
ing the resectability of the lesion. The positive predictive 
value came to 83%, while the negative predictive value to 
100%. The Kappa compatibility index in comparison with a 
surgical findings came to 0.85714.
In the evaluation of lymph nodes the MRI and MRCP were 
marked by 83% sensitivity, 56% specificity and 67% exact-
ness. The positive predictive value came to 65%, whereas 
the negative predictive value came to 75% (Figure2).
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In the evaluation of blood vessels infiltration MRI were 
marked by 62% sensitivity, 58% specificity and 60% exact-
ness (Figure 2). The positive prediction index came to 56%, 
while the negative prediction index came to 63%.
The size of the tumor detected within the pancreas in the 
MRI examination was compared with the size of tumor in 
the histopathological examination. The average size of the 
lesion in the MRI examination came to 2.7±1.2 cm (2.0–6.0 
cm), in the histopathological examination 3.9±2 cm (1.5–9.0 
cm) (Figure 3).
The lesion within the pancreas revealed the most frequent-
ly reduced intensity of the signal in T1 – weighted sequence 
compared to the correct pancreatic parenchyma, after an 
intravenous administration of Gd-DTPA did not undergo 
any contrasting reinforcement (hypointense signal). In T2-
weighted sequence isointense signal was revealed by 41% 
of tumors, hypointense – 36% and hyperintense – 23% of 
pancreatic tumors (Figure 4).
Discussion
Adenocarcinoma deriving from the ductal epithelium is 
the most frequent form of pancreatic carcinoma and most 
frequently localizing within the head of the organ [7]. 
Pancreatic carcinoma is a disease connected with a high 
mortality – no more than 3% of the suffering patients sur-
vives a 5-year period from time of diagnose was stated [8,9]. 
The majority of the affected patients dies within 1–2 years. 
In a study of 174 patients, Freeny found that the average 
survival rate after resection was 14 months, while the sur-
vival rate after palliative (biliary or gastrointestinal bypass) 
or no treatment were 8 months and 5 months, respectively 
[10]. The unfavorable prognosis is connected with an early 
spreading of cancerous cells beyond the pancreatic gland 
as well as the long period or asymptomatic development of 
the disease [3,11]. An early diagnosis of the tumor as well 
as the correct defining of the progression stage are of the 
key importance, as they are linked with undertaking the 
appropriate treatment. At this point of time only surgical 
treatment of early diagnosed tumors gives patients chance 
for recovering [3,12]. This, however concerns only a small 
percentage of those affected, in whose the presence of the 
cancerous lesion was diagnosed early, that is when the 
tumor diameter is no bigger than 2 cm, when the infiltra-
tion of peripancreatic blood vessels, enlarged lymph nodes 
and remote metastases is not determined (tumors T1a and 
T1b according to UICC classification). The appropriate pre-
operative determination of the pancreatic carcinoma stag-
ing allows for avoiding serious operations connected with a 
long hospitalization of the patients with an advanced stage 
of the disease [3,11].
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Figure 1.  Sensitivity, specifi city, and exactness of MRI and MRCP in 
determining the nature of a lesion and its resectability.
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Figure 2.  Sensitivity, specifi city, and exactness of MRI and MRCP in 
the recognition of lymph node and blood vessel infi ltration.
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Figure 3.  The average size of tumor mass in MR and in intraoperative 
fi ndings.
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Figure 4.  MRI signal intensity in T1-weighted time, in T1 after 
intravenous administration of a paramagnetic contrast 
medium (Gd-DTPA), and in T2-weighted time.
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In case of a clinical suspicion of the pancreatic tumor 
new radiological non – invasive methods of imaging, such 
as US, CT, MRI have a special place and task. They serve 
either the exclusion or confirmation of the disease as well 
as determining stage of progression of the disease in order 
to single out a group of the ill with a localized cancerous 
process qualified for a surgical treatment [3,13,14]. In our 
centre, like in numerous other centers, the presence of 
remote metastases, the infiltration of blood vessels (other 
than peripancreatic) as well as a considerable local pro-
gression of the tumor with the affliction of adjacent organs 
(other than duodenum), and blood vessels in particular, are 
regarded as criteria of unresectability of the tumor.
In recent years the technology of nuclear magnetic reso-
nance has been developing dynamically. The method does 
not utilize ionizing radiation and its additional merit is 
the possibility of multiplane examination planning, three-
dimensional presentation of images. Contrast media (gado-
pentetate dimeglumine) used in the MRI examination may 
be safely administered to patients allergic to commonly 
used in radiology compounds containing iodine as well as 
in the case of patients with the impaired function of kid-
neys [15]. Furthermore, in the course of a single treatment, 
MRI allows for revealing venuous and arterial peripancre-
atic vessels as well as bile ducts and the pancreatic duct 
without the necessity of applying contrast media [14].
Recently, the sequences successfully used in diagnostics of 
the pancreas diseases are the following: pulsating sequenc-
es of the spin echo in T1-weighted time with or without 
the fat saturation, gradient echo sequences with the breath 
held, with an intravenous administration of the contrast 
medium or without Gd-DTPA, conventional spin echo 
sequences and quick pulsating turbo spin echo sequences 
with the fat saturation in T2-weighted time as well as 
Flash sequences (fast low-angle shots) in T1-weighted time 
[4,16,17] (Figure 5). According to those authors, in many 
cases MRI allows for the detection of small, non – changing 
contours of the pancreas tumors. Enables the differentia-
tion of a chronic inflammation with a normal findings as 
well as the chronic inflammation with a local enlargement 
(inflammatory tumor) with pancreatic cancer [4,16,17].
The most commonly encountered MRI image of the pancre-
atic carcinoma in our examinations was a pathological mass 
with indistinct outlines and the diameter of approximately 
3 cm revealing a reduced signal intensity in T1-weighted 
sequence in comparison to the correct pancreatic paren-
chyma (except lymphoma, which revealed the hyperin-
tense signal) or the isointense signal (in three cases), which, 
most probably is connected to the presence of inflamma-
tory alterations in the surrounding parenchyma. After the 
intravenous administration of Gd-DTPA the mass did not 
enhance and reveal hypointense signal in comparison with 
the remaining pancreatic parenchyma (Figure 5). Non-spe-
cific, extracellular paramagnetic contrast media improve a 
detection of pancreatic tumors due to obtaining appropriate 
contrast gradient between cancerously altered and richly 
vascularized parenchyma of the organ. The skimpy vascu-
larization as well as the fibrous histological nature of the 
pancreatic carcinoma are responsible for the low intensity 
of the signal as well as indistinct, blurred contours of the 
tumor [17].
Revealing tumors in the T2-weighted sequence is more dif-
ficult because the lesions may bear the following signals: 
the isointense, the slightly hypointense or the hyperintense 
[18]. In the collected clinical material the isointense sig-
nal in the T2- weighted sequence was indicated by 41% of 
tumors, the hypointense by 36% and the hyperintense by 
23% of tumors.
The local staging of the tumor and, in particular, its relation 
to the blood vessel structures, such as: the portal vein, the 
splenic vein, the superior mesenteric vein, the celiac trunk, 
the superior mesenteric artery, the hepatic artery, the infe-
rior vena cava as well as the left kidney artery, belong to 
the most critical factors that decide about the tumor resect-
ability [19–21].
In our own research material, when applied the criteria of 
the vessel infiltration of the afore-mentioned authors, the 
MRI indicated 62% sensitivity, 58% specificity, 60% accuracy.
The assessment of the liver is an important factor in the 
staging of pancreatic cancer patients, since pancreatic 
tumors tend to metastasize early into the liver [22]. The 
presence of at least one metastasis indicates a generaliza-
tion of the disease and a unresectability of the tumor for 
the oncological reasons [1].
According to a number of authors the MRI examination 
strengthened by a contrast media plays an important part 
in a disclosure of metastases in the liver. [4,23]. This has 
also been confirmed by our research in which the metas-
tases within the liver indicated non-specificity in the MRI 
examination. In the MRI method within the T1-weighted 
sequence those lesions indicated hypointense signal the 
most frequently before and after the contrast media had 
been applied intravenously, whereas in the T2-weighted 
sequence those lesions were slightly hyperintense with or 
without the central necrosis.
In the possessed research material the MRI indicated a low 
sensitivity in revealing metastases in the peritoneum. In 
the case of two patients the performed laparotomy pointed 
out to a presence of the tumor infiltrations in the perito-
neum, which was not disclosed through the MRI method. 
Figure 5.  RF FAST T1-hypointense mass located in the head of the 
pancreas.
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Thus, laparoscopy and laparotomy play an important part 
in the pancreatic carcinoma staging assessment, however, 
those are both invasive and costly methods. The metastases 
in the liver and peritoneum can be merely of several milli-
meters in size, thus invisible in the MRI examination [24].
Another important point in the diagnosis of pancreatic car-
cinoma is the assessment of the lymph nodes, in particular, 
the groups of the nodes other than peri-pancreatic (mesen-
teric, liver, etc.), in which the presence of metastases elimi-
nates the occurrence of tumor resectability [22].
According to Ichikawa, whose assessment is based on the 
diameter of lymph nodes, the value of the negative predica-
tion of the MRI in the evaluation of lymph nodes is low and 
amounts to 57% [5].
In the collected research material the MR examination 
indicated the following values of the lymph nodes assess-
ment: sensitivity 83%, specificity 55%, accuracy 67%. The 
index of the positive predication amounted to 65%, where-
as its negative value 75%. In the group of patients, whose 
pancreas lesions were considered as resectable on the 
basis of MRI and MRCP examinations, 9 cases presented 
no enlargement of the lymph nodes, whereas 4 cases indi-
cated the presence of metastases in the adjacent lymph 
nodes in the histopathological examination. It is difficult 
to detect the peripancreatic lymph nodes slightly enlarged 
because of the limitations of the resolution method and 
the presence of a number of minor structures (arteries, 
veins) in the peripancreatic area as well as a slight dis-
crepancy in the signal intensity to the surrounding tissues 
[5]. In our clinical research by MRI method in the T1-
weighted sequence the enlarged lymph nodes indicated an 
hypointense signal towards the surrounding fatty tissue, 
whereas in the sequences of fat saturation the signal was 
isointense. However, in T2-weighted, isointense signals of 
a higher or lower value were received and most frequent-
ly hypointense signals in the fat saturated sequences.
Enriching the conventional MRI examination of the abdom-
inal cavity with an MRCP examination, based on the use of 
quick sequences in the T2-heavily weighted time, provides 
invaluable data as to the condition of the bile duct and the 
pancreatic duct [25].
In the possessed clinical material a projection technology 
HASTE was applied for the hydrography of the MRI method 
(Figure 6).
Owing to the availability of a multiplane examination, the 
MRCP method allows for an exact depiction of the location 
of the stenosis, extent, and degree as well as the assess-
ment of the segmental and/or extensive irregularities of the 
bile duct and the pancreatic duct, depending on the size 
and location of the pancreatic tumor [25,26]. The discrete 
duct alterations seen in the MRCP method may be of great 
weight for the diagnosis of minor, indiscrete pancreatic 
tumors as well as in the differential diagnosis of a chronic 
inflammation [26,27].
In the possessed research material the typical duct altera-
tions to be observed in the patients ill with pancreatic car-
cinoma were the following: a sudden closure of the pancre-
atic duct (50%), an irregular stenosis frequently followed 
by a sudden extended proximal segment of the main duct 
with, either extended or not, minor secondary ducts and 
so called a “double duct sign” (Figure 6). The “Double duct 
sign” refers to both the extension of the bile duct and the 
pancreatic duct. This quality was observed in 14 out of 37 
patients ill with pancreatic carcinoma (38%). The obtained 
images of the bile duct and the pancreatic duct referring to 
the staging of the pancreatic carcinoma correspond to those 
data reported by other authors [28,29].
The carried out research showed that MRI in connection 
with MRCP indicate a high accuracy in the detection of 
the presence of a pathological mass in the pancreas (100%), 
description of its character and assessment of the staging 
degree of the pancreatic carcinoma. In the statistical analy-
sis a high Kappa index was obtained in comparison with 
the intra-operative imaging (0.85714) as to the evaluation 
of resectability lesions. The unresectability of malignant 
tumors indicated on the basis of the MR evaluation criteria 
enriched with a sequence of MRCP was confirmed by lapa-
rotomy in all the patients (n=27). The diagnostic mistakes 
dealt with the group named as the falsely negative, but not 
the falsely positive one.
Estimating tumor size in preoperative staging of pancreat-
ing carcinoma showed a tendency to understage tumor size 
in this study population what is also conclusive with find-
ings of Bley TA et all [30].
In the case of the pathological mass diagnosis within the 
pancreas the most difficult diagnostic problem is to differ-
entiate a cancer from an inflammatory tumor. No radio-
logical diagnostic method can grant a 100% certainty of 
the diagnosis accuracy [31,32]. The diagnosis as well as the 
performance of an appropriate differentiation is a particu-
larly responsible task as a distant prognosis and a thera-
peutic procedure in both diseases differ significantly. In the 
case of the chronic inflammation the aim of the surgery (by 
Berger's or Frey's method) is to eliminate the pain and other 
symptoms, whereas in the pancreatic carcinoma the objec-
Figure 6. MRCP HASTE – “double duct sign”.
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tive of a surgery is to remove the carcinogenic tissue (by 
Whipple's method).
It is not easy to differentiate between a cancer and an 
inflammatory tumor for the reason that the pancreatic car-
cinoma is frequently accompanied by secondary inflamma-
tory alterations, which affects the parenchyma signal inten-
sity in the MRI examination. On the other hand, a cancer 
may develop from the chronic inflammatory alterations, the 
occurrence of which poses a higher risk of cancer [32,33].
Relatively frequent is the indication of the chronic inflam-
mation alterations connected with a disturbed outflow of 
the pancreatic juice in the pancreatic duct cancer [34]. A 
small tumor located in the proximity of the pancreatic duct, 
indiscernible in the radiological examinations, may cause 
the duct's narrowing as well as its acute inflammatory con-
dition in the gland. Moreover, the inflammatory alterations 
can lead to the mistakes as to the assessment of the size 
of the tumor. It is also to be underlined that a developing 
inflammation process may on many occasions be the cause 
of local lymphodenopathy, which may indicate the presence 
of metastasis in the lymph nodes [32].
The clinical symptoms reported by the patients with a 
chronic inflammation, such as returning fits of an acute 
pain in the upper abdomen, also to be felt in the back, a 
decline in the body weight, all the symptoms connected 
with narrowing of the common bile duct, the pancreatic 
duct or the duodendum prevail in the clinical picture of 
both the chronic inflammation and the pancreatic carcino-
ma [35]. The adenocarcinoma to be found in approximately 
70% within the head of the pancreas shows a similar local-
ization to the chronic inflammatory alterations.
Despite an enormous progress in the development of radio-
logical imagination, to have occurred in the last decade, 
none of the modern diagnostic methods can be considered a 
100% accuracy method in differentiating a pancreatic carci-
noma from an inflammatory tumor [35]. Certain symptoms, 
for instance, the presence of calcifications dispersed in the 
pancreas parenchyma as well as the images of extended 
duct structures within the tumor mass showed by MRCP 
examination speak in favor of an inflammatory tumor 
occurrence [21]. In the studies conducted by Van Gulik and 
partners out of 220 pancreato-duodenectomy examinations 
conducted for the cause of a pancreatic carcinoma detection, 
a chronic inflammation was diagnosed in the 6% of patients 
by the histopathological examinations [36]. Whereas Moussa 
and partners reported that out of 64 patients, operated on 
because of the chronic pancreatic inflammation, the pres-
ence of cancer was confirmed histopathologically in 4 cases 
[37]. However, in Zagrafos and partners the pancreatic car-
cinoma was diagnosed in 4 cases out of 250 altogether [35].
In the conducted research the presence of a chronic inflam-
mation with an inflammatory tumor was diagnosed in the 
pancreas head in 6 patients aged 40–50. In the MRI exami-
nations in the T1-weighted sequence those lesions showed 
a slightly decreased or a relatively increased signal intensity 
compared to the pancreas parenchyma, and in the sequences 
performed with the use of Gd-DTPA revealed an impaired 
contrast enhancement. In MRCP examinations irregular 
extensions of the main pancreatic duct, distal to the narrow-
ing place, as well as the extended secondary ducts together 
with pseudocysts were frequently observed. In all patients 
a good degree of the Wirsung's duct vision was obtained 
together with the duct's side branches extended all along 
their lengths. Only the presence of the pancreatic pseudocysts 
seemed to cause segmental disturbance of the pancreatic 
ducts vision. Those cases required a greater number of MRCP 
scans from a variety of angles in relation to the pilot scans.
In the clinical group (n=48) in MRI and MRCP the pres-
ence of cancerogenic lesions was mistakenly diagnosed in 
the case of 1 patient with the features of pancreatic inflam-
matory alterations. A hypointense area with irregular con-
tours bearing all features of cancerogenic alterations were 
revealed within the head in the T1-weighted sequence. The 
conducted histopathological analysis indicated the pres-
ence of alterations of the inflammatory type. In the case 
of another patient, who showed a presence of adenocarci-
noma (T2 according to TNM classification), the MRI and 
MRCP examinations indicated the inflammatory alterations 
incorrectly.
On the basis of the conducted studies it appears that the 
MRI and MRCP examinations are to be applied as the diag-
nosis enrichment when despite all clinical and laboratory 
symptoms in favor of the presence of pancreatic carcinoma, 
the disease picture is still equivocal in other radiological 
methods. For the sake of a higher accuracy in describing 
the disease staging degree the MRI and MRCP examina-
tions ought to be carried out for those pancreatic carcinoma 
patients who face a surgery. The MRI and MRCP examina-
tions seem to be indispensable in the differential diagnosis 
of an inflammatory tumor and a cancer [27,38].
The MRI supplemented by a MRCP sequence provides an 
opportunity of a complex evaluation of the upper abdomen 
that can outperform, in certain aspects, the other applied 
methods. The MR sequences allow to receive images of any 
diameter, in fact, in two complementary diagnostic times 
– T1 and T2. Multi-sequential MR/MRCP examination is 
capable of combining the assets of the invasive methods 
and becoming a decisive method in a number of difficult 
diagnostic cases.
In conclusion, the MR and MRCP examinations fulfill the 
criteria of their applicability to the pancreatic carcinoma 
diagnosis thanks to the high sensitivity, specificity, and 
accuracy.
Conclusions
1.  The Magnetic Resonance (MR) connected with the 
Magnetic Resonance Cholangiopancreatography (MRCP) 
is suitable method in the diagnosis and assessment of 
respectability of pancreatic tumors.
2.  MR and MRCP are an accurate, high specify and nonin-
vasive technique in the preoperative evaluation of pan-
creatic malignancy, particularly useful in the differential 
diagnostics and treatment decision.
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